Diadynamic and Exercises in Knee Osteoarthritis
Eefficacy of Diadynamic Currents Associated Exercise in Patients With Knee Osteoarthritis
1 other identifier
interventional
60
1 country
1
Brief Summary
Osteoarthritis represents failed repair of joint damage resulting from stresses initiated by any joint or periarticular tissue abnormality. The rate of progression varies among persons and within a knee over time. The symptoms and signs of knee osteoarthritis include pain, stiffness, reduced joint motion, and muscle weakness. Long-term consequences can include reduced physical activity, deconditioning, impaired sleep, fatigue, depression, and disability.This reduction in activity to avoid pain (kinesiophobia) to evade the onset of pain, especially in the acute phase, limiting their compliance with effective rehabilitation strategies such as regular exercises. Physical medicine has a wide range of analgesic anti-inflammatory and muscle stimulating treatment methods. Both diadynamic and TENS currents have become the most frequently implemented electrotherapeutic methods. The impact of diadynamic currents consists of analgesic effects and specific dynamics during the formation of physiological processes in tissues. They occur during the administration of the current and lasts up to a few hours after the treatment has been terminated. One of the theories explaining the analgesic effect of diadynamic currents is the gate control theory of pain by Wall and Melzack. Recently, another theory has become very popular. It explains the analgesic effect provoked by bodies characterized as polypeptides called endorphins. Electric stimulation using diadynamic currents generates an increase in the amount of endorphins in a system. Although the analgesic impact of TENS therapy is well known, Diadynamic currents therapies have not been studied in knee osteoarthritis pain conditions. Therefore, the aim of the present study was to investigate the medium-term effects of Diadynamic currents combined with exercise on pain and disability in patients with osteoarthritis of the knee.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2021
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2021
CompletedFirst Submitted
Initial submission to the registry
November 10, 2021
CompletedFirst Posted
Study publicly available on registry
December 16, 2021
CompletedDecember 16, 2021
November 1, 2021
3 months
November 10, 2021
December 15, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change in pain intensity
Pain intensity measured by the numeric pain rating scale (0-10) with a minimal clinically important change set at two points
outcomes were collected at baseline (before randomization) and 8 weeks from baseline by the same blinded evaluator.
Change in Disability
Disability measured using the Lequesne questionnaire,14 which consists of 11 questions about pain, discomfort, and function. Scores range from 0 to 24 (from 'no' to 'extremely severe' dysfunction).
outcomes were collected at baseline (before randomization) and 8 weeks from baseline by the same blinded evaluator.
Secondary Outcomes (5)
Change in Medication intake (Paracetamol) for knee pain relief
outcomes were collected at baseline (before randomization) and 8 weeks from baseline by the same blinded evaluator.
Change in Mobility and balance
outcomes were collected at baseline (before randomization) and 8 weeks from baseline by the same blinded evaluator.
Change in Range of motion
outcomes were collected at baseline (before randomization) and 8 weeks from baseline by the same blinded evaluator.
Change in Muscular strength
outcomes were collected at baseline (before randomization) and 8 weeks from baseline by the same blinded evaluator.
Change in Physical activity
outcomes were collected at baseline (before randomization) and 8 weeks from baseline by the same blinded evaluator.
Study Arms (2)
Group Diadynamic and Exercises
EXPERIMENTALGroup Diadynamic and Exercises received Diadynamic currents associated to Exercise three times a week for 8 weeks following initial assessment (n=30, 60 knees) Diadynamic currents was performed with the following parameters: application of the two-phase current and then the long-term one. Each current was applied for 4 minutes on the medial and lateral sides of the knee.
Group Exercises
EXPERIMENTALGroup Exercises received only exercises three times a week for 8 weeks following initial assessment (n=30, 60 knees).
Interventions
Diadynamic currents was performed followed by exercises (divided into Phase-1, Phase-2 and Phase-3 during eight weeks with three sessions a week).
The intervention was divided into Phase-1, Phase-2 and Phase-3 during eight weeks with three sessions a week. Each session lasted 45 minutes.
Eligibility Criteria
You may qualify if:
- aged from 50 and 75;
- symptomatic knee osteoarthritis for at least three months;
- visual analogue scale12 score above 3 and
- radiographic knee osteoarthritis (uni or bilateral) compatible with Kellgren-Lawrence13 grade two or higher.
You may not qualify if:
- contraindication to laser application (e.g. cancer and insulin-dependent diabetes);
- inability to perform the assessment or treatment;
- continuous use of anti-inflammatory drugs,
- symptomatic hip osteoarthritis
- physiotherapeutic knee treatment within the last 3 months.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Raquel Aparecida Casarotto
São Paulo, Brazil
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Raquel Ap Casarotto, PhD
USP
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 10, 2021
First Posted
December 16, 2021
Study Start
January 1, 2021
Primary Completion
April 1, 2021
Study Completion
August 1, 2021
Last Updated
December 16, 2021
Record last verified: 2021-11
Data Sharing
- IPD Sharing
- Will not share